AMENDMENT TO AGREEMENTNomination and Standstill Agreement • March 22nd, 2016 • Sarissa Capital Management LP • Pharmaceutical preparations
This AMENDMENT (the “Amendment”) is made as of March 21, 2016, by and among AEGERION Pharmaceuticals, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and the entities listed on Schedule A hereto (collectively, the “Sarissa Group”).
